Skip to content
Screener

Current ratio at other companies

AutoZone logo
AutoZoneAZO
0.9×0.0×
Synopsys logo
SynopsysSNPS
1.4×-5.6×
Monster Beverage logo
Monster BeverageMNST
3.3×-0.1×
Nucor logo
NucorNUE
2.9×+0.4×
Dycom Industries logo
Dycom IndustriesDY
2.6×-0.3×
Nordson logo
NordsonNDSN
2.6×0.0×

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.96B+37.6%
Enterprise value$1.93B

Returns & leverage

See full
Debt / equity-0.2×

Where this comes from

Calculated from Alamar Biosciences’s reported figures.

Based on the most recent quarter.

The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026. Open the filing →

Filed
May 8, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-213424

FAQ

What is Alamar Biosciences's current ratio?
Alamar Biosciences (ALMR) reported current ratio of 5.9× in Q1 2026.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about Alamar Biosciences's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude